Abstract
Objectives
Norepinephrine use in patients after cardiac surgery is controversial because of the fear that norepinephrine might decrease kidney function through regional vasoconstriction. Accordingly, we studied the renal effects of norepinephrine use for hypotensive vasodilatation after cardiac surgery.
Design and setting
Retrospective controlled study in the cardiothoracic ICU of tertiary hospital.
Patients
100 cardiac surgery patients with post-operative hypotensive vasodilatation and 100 control cardiac surgery patients.
Intervention
Treatment of hypotension (MAP<70 mmHg) with continuous norepinephrine infusion.
Measurements and results
We collected data on demographic and surgical characteristics, haemodynamics, serum creatinine and mortality. Just after surgery the norepinephrine group had a significantly higher mean central venous pressure, lower mean arterial pressure, and lower systemic vascular resistance index with a similarly elevated mean cardiac index. Despite norepinephrine administration at a mean peak dose of 7.3±6.4 µg/min the mean post-operative change in creatinine was not different between two groups on days 0, 2 or 4 after surgery.
Conclusions
Norepinephrine does not increase post-operative serum creatinine concentrations in patients with hypotensive vasodilatation after cardiac surgery. Concerns related to its potential adverse effects on the kidney function in this setting appear unjustified.
Similar content being viewed by others
Reference
Argenziano M, Chen JM, Choudhri AF, Cullinane S, Garfein E, Weinberg AD, Smith CR, Rose EA, Landry DW, Oz MC (1998) Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 116:973–980
Gomes WJ, Carvalho AC, Palma JH, Teles CA, Brance JNR, Silas MG, Buffolo E (1998) Vasoplegic syndrome after open heart surgery. J Cardiovasc Surg 39:619–623
Kristof AS, Magder S (1999) Low systemic vascular resistance state in patients undergoing cardiopulmonary bypass. Crit Care Med 27:1121–1127
Mekontso-Dessap A, Houel R, Soustelle C, Kirsch M, Thebert D, Loisance DY (2001) Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg 71:1428–1432
Bellomo R, DiGiantomasso D (2001) Noradrenaline and the kidney; friends or foes. Crit Care 5:294–298
Sinsteden TD, O'Neil TJ, Hill S, Lifschitz MD, Stein JH (1989) The role of high-energy phosphate in norepinephrine-induced acute renal failure in the dog. Circulation Res 59:93–104
Schafferhans K, Heidbreder E, Grimm D, Heidland A (1986) Norepinephrine-induced acute renal failure: beneficial effects of atrial natriuretic factor. Nephron 44:240–244
Chardigny C, Jebara VA, Acar C, Descombes JJ, Verbeuren TJ, Carpentier A, Fabiani JN (1993) Vasoreactivity of the radial artery: comparison with the internal mammary gastroepiploic arteries with implication for coronary artery surgery. Circulation 88:115–127
Chanda J, Canver CC (2001) Reversal of preexisting vasospasm in coronary artery conduits. Ann Thorac Surg 72:476–480
Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J (1998) Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 104:343–348
Yeboah ED, Peter A, Pead JL (1972) Acute renal failure and open heart surgery. BMJ 1:415–418
Conlon PJ, Stanfford-Smith M, White WD, Newman MF, King S, Winn MP, Landolfo K (1999) Acute renal failure following cardiac surgery. Nephrol Dial Transplant 14:1158–1162
Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT (1998) Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. Ann Intern Med 128:194–203
Parsonnet V, Dean D, Bernstein AD (1989) A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 79:I3–I12
Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R (1999) European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16:9–13
Liu JJ, Doolan LA, Xie B, Chen JR, Buxton BF (1997) Direct vasodilator effect of milrinone, an inotropic drug, on arterial coronary bypass grafts. J Thorac Cardiovasc Surg 113:108–113
Gitter R, Anderson JM, Jett GK (1996) Influence of milrinone and norepinephrine on blood flow in canine internal mammary artery grafts. Ann Thorac Surg 61:1367–1371
Lote CJ, Harper L, Savage COS (1996) Mechanisms of acute renal failure. Br J Anaesth 77:82–89
Feneck RO, Sherry KM, Withigton PS, Oduro-Dominah A (2001) Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J Cardiothorac Vasc Anesth 15:306–315
Feneck RO (1992) Intravenous milrinone following cardiac surgery. I. Effects of bolus infusion followed by variable dose maintenance infusion. The European Milrinone Multicentre Trial Group. J Cardiothorac Vasc Anesth 5:554–562
Feneck RO (1992) Intravenous milrinone following cardiac surgery. II. Influence of baseline hemodynamics and patients factors on therapeutic response. The European Milrinone Multicentre Trial Group. J Cardiothorac Vasc Anesth 5:563–567
Kikura M, Levy JH, Michelsen LG, Shanewise JS, Bailey JM, Sadel SM, Szlam F (1997) The effect of milrinone on hemodynamics and left ventricular function after emergence from cardiopulmonary bypass. Anesth Analg 85:16–22
Gold J, Cullinane S, Chen J, Seo S, Oz MC, Oliver JA, Landry DW (2000) Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure. Am J Cardiol 85:506–508
Gold JA, Cullinane S, Chen J, Oz MC, Oliver JA, Landry DW (2000) Vasopressin as an alternative to norepinephrine in the treatment of milrinone-induced hypotension. Crit Care Med 28:249–252
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by the Austin and Repatriation Medical Centre Intensive Care Research Fund
Rights and permissions
About this article
Cite this article
Morimatsu, H., Uchino, S., Chung, J. et al. Norepinephrine for hypotensive vasodilatation after cardiac surgery: impact on renal function. Intensive Care Med 29, 1106–1112 (2003). https://doi.org/10.1007/s00134-003-1810-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-003-1810-3